Status:
TERMINATED
A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will assess the safety, efficacy and effect on quality of life of switching kidney transplant patients from reduced dose EC-MPS treatment due to gastrointestinal problems to a higher than t...
Eligibility Criteria
Inclusion
- adult patients, \>=18 years of age;
- first or second kidney transplant;
- EC-MPS therapy for \>=6 months, with a stable dose for \>=2 months;
- lower than recommended dose of EC-MPS (\<1440g/day) due to gastrointestinal complaints.
Exclusion
- patients who have participated in this study before;
- patients currently participating in another clinical trial, or who participated in one during the last 30 days.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00420472
Start Date
March 1 2007
Last Update
November 20 2007
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin, Germany, 10117
2
Berlin, Germany, 13353
3
Cologne, Germany, 51109
4
Dresden, Germany, 01307